Skip to main content
. 2023 Mar 24;20(3):181–195. doi: 10.20892/j.issn.2095-3941.2023.0002

Figure 2.

Figure 2

The bsAbs targeting immunomodulatory checkpoints. The checkpoint-targeted bsAbs are mainly divided into three categories: targeting dual inhibitory checkpoints (①); targeting co-stimulatory and inhibitory checkpoints (②); and targeting immunomodulatory checkpoints and non-checkpoint targets (③④). TAA, tumor-associated antigen; PD-L1, programmed death-ligand 1; TGF-β, transforming growth factor-β.